Gene therapy for diabetic ischemic disease
AssigneeAnGes MG, Inc.
InventorsRyuichi Morishita, Toshio Ogihara
Life of this patent
Estimating the term…
Abstract
It is possible to stimulate the angiogenesis of an ischemic site declined by diabetes and to recuperate ischemic disease by administering HGF (hepatocyte growth factor) gene to the diabetic ischemic.
Claims8
A method for the treatment of diabetic ischemic disease in a subject, comprising nonivasively administering a therapeutically effective amount of a hepatocyte growth factor (HGF) gene directly to a muscle of an ischemic site, and measuring blood flow, wherein expression of the HGF gene increases blood flow in the diabetic subject compared to the blood flow of an HGF-treated non-diabetic subject with ischemic disease, thereby treating the diabetic ischemic disease.
Dependencies are inferred from the claim text.